keyword
https://read.qxmd.com/read/38628588/assessment-of-new-onset-heart-failure-prediction-in-a-diabetic-population-using-left-ventricular-global-strain-a-prospective-cohort-study-based-on-uk-biobank
#21
JOURNAL ARTICLE
Siwei Chen, Cong Chen, Longxuan Zheng, Wenke Cheng, Xiancong Bu, Zhou Liu
BACKGROUND: Impaired glucose utilization influences myocardial contractile function. However, the prognostic importance of left ventricular global radial strain (LV-GRS), left ventricular global circumferential strain (LV-GCS), and left ventricular global longitudinal strain (LV-GLS) in predicting new-onset heart failure (HF) in a population with diabetes is unclear. METHODS: The study design is prospective cohort from the UK Biobank. Totally 37,899 participants had a complete data of cardiac magnetic resonance (CMR), of which 940 patients with diabetes were included, and all the participants completed follow-up...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38628580/turning-the-tides-achieving-rapid-and-safe-glucose-control-in-adolescents-with-suboptimally-controlled-type-1-diabetes-using-advanced-hybrid-closed-loop-systems
#22
JOURNAL ARTICLE
Valeria Castorani, Andrea Rigamonti, Giulio Frontino, Elisa Morotti, Federica Sandullo, Francesco Scialabba, Francesca Arrigoni, Benedetta Dionisi, Riccardo Foglino, Camilla Morosini, Gabriele Olivieri, Riccardo Bonfanti
AIM: Many adolescents with T1D experience a decline in metabolic control due to erratic eating habits and subpar adherence to treatment regimens. The objective of our retrospective observational study was to assess the effect of the Tandem Control IQ (CIQ) advanced hybrid closed-loop (AHCL) system on a cohort of adolescents with suboptimal glucose control. METHODS: We retrospectively evaluated 20 non-adherent patients with T1D, who were inconsistently using Multiple Daily Injections (MDIs) and flash glucose monitoring and were subsequently started and on CIQ...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38627329/hypertension-and-diabetes-but-not-leptin-and-adiponectin-mediate-the-relationship-between-body-fat-and-chronic-kidney-disease
#23
JOURNAL ARTICLE
Robin Lengton, Friedo W Dekker, Elisabeth F C van Rossum, Johan W de Fijter, Frits R Rosendaal, Ko Willems van Dijk, Ton J Rabelink, Saskia Le Cessie, Renée de Mutsert, Ellen K Hoogeveen
PURPOSE: Obesity may promote kidney damage through hemodynamic and hormonal effects. We investigated the association between body mass index (BMI), total body fat (TBF) and chronic kidney disease (CKD) and whether hypertension, diabetes, leptin and adiponectin mediated these associations. METHODS: In this cross-sectional analysis of the Netherlands Epidemiology of Obesity study, 6671 participants (45-65 y) were included. We defined CKD as eGFR <60 ml/min/1...
April 16, 2024: Endocrine
https://read.qxmd.com/read/38627328/studies-on-treatment-within-the-scope-of-medical-biotechnology-for-pancreatic-diseases
#24
REVIEW
Dilara Aylar, Ayse Karatug Kacar
The pancreas is made of two compartments: the exocrine pancreas, a source of digestive enzymes, and the endocrine islets which produce vital hormones. Distinct diseases could arise in the pancreas such as diabetes, neuroendocrine tumors, pancreatitis, and pancreatic cancers. Various treatment methods are being researched against these diseases. Treatment with recombinant proteins, therapeutic antibodies, vaccination, gene therapy, tissue engineering, and stem cell treatment are treatment methods. Furthermore, biomarkers are important for both treatment and diagnosis...
April 16, 2024: Molecular Biotechnology
https://read.qxmd.com/read/38626913/therapy-combining-glucagon-like-peptide-1-receptor-agonist-with-sodium-glucose-cotransporter-2-inhibitor-suppresses-atherosclerosis-in-diabetic-apoe-deficient-mice
#25
JOURNAL ARTICLE
Masahiro Takubo, Kentaro Watanabe, Hitoki Saito, Genta Kohno, Hisamitsu Ishihara
Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) have beneficial effects on cardiovascular disease in addition to their glucose-lowering effects. We directly compared the effects of these drugs when used individually or in combination on cardiovascular atherosclerotic lesion development using diabetic ApoE-deficient hyperlipidemic mice. Methods We treated ApoE-deficient mice with streptozotocin and nicotinamide, generating a type 2 diabetes model...
April 16, 2024: Experimental and Clinical Endocrinology & Diabetes
https://read.qxmd.com/read/38626912/prevalence-and-incidence-of-medication-treated-diabetes-and-pattern-of-glucose-lowering-treatment-during-the-covid-19-pandemic-real-world-data-from-the-electronic-greek-prescription-database
#26
JOURNAL ARTICLE
Christos Siafarikas, Georgios Karamanakos, Konstantinos Makrilakis, Anastasios Tsolakidis, Konstantinos Mathioudakis, Stavros Liatis
OBJECTIVES: The aim of this study was to investigate the prevalence and incidence of medication-treated diabetes mellitus and the evolving patterns of glucose-lowering treatments, the year before and, during the first two years of the COVID-19 pandemic. METHODS: Data from the Greek electronic prescription database were analyzed for the years 2019, 2020, and 2021. The study population included individuals with active social security numbers. Prevalence and incidence rates were calculated based on the dispensing of glucose-lowering medications, according to their unique ATC (anatomical therapeutic chemical) code...
April 16, 2024: Experimental and Clinical Endocrinology & Diabetes
https://read.qxmd.com/read/38626909/glucagon-like-peptide-1-based-therapies-a-new-horizon-in-obesity-management
#27
JOURNAL ARTICLE
Jang Won Son, Soo Lim
Obesity is a significant risk factor for health issues like type 2 diabetes and cardiovascular disease. It often proves resistant to traditional lifestyle interventions, prompting a need for more precise therapeutic strategies. This has led to a focus on signaling pathways and neuroendocrine mechanisms to develop targeted obesity treatments. Recent developments in obesity management have been revolutionized by introducing novel glucagon-like peptide-1 (GLP-1) based drugs, such as semaglutide and tirzepatide...
April 16, 2024: Endocrinology and Metabolism
https://read.qxmd.com/read/38626908/young-onset-diabetes-in-east-asians-from-epidemiology-to-precision-medicine
#28
JOURNAL ARTICLE
Juliana C N Chan, Chun-Kwan O, Andrea O Y Luk
Precision diagnosis is the keystone of clinical medicine. In East Asians, classical type 1 diabetes is uncommon in patients with youngonset diabetes diagnosed before age of 40, in whom a family history, obesity, and beta-cell and kidney dysfunction are key features. Young-onset diabetes affects one in five Asian adults with diabetes in clinic settings; however, it is often misclassified, resulting in delayed or non-targeted treatment. Complex aetiologies, long disease duration, aggressive clinical course, and a lack of evidence-based guidelines have contributed to variable care standards and premature death in these young patients...
April 16, 2024: Endocrinology and Metabolism
https://read.qxmd.com/read/38625535/barriers-to-the-use-of-insulin-therapy-and-potential-solutions-a-narrative-review-of-perspectives-from-the-asia-pacific-region
#29
REVIEW
Roger Chen, Azizul Hasan Aamir, Mohammod Feroz Amin, Pongamorn Bunnag, Siew Pheng Chan, Lixin Guo, Mohammad E Khamseh, Viswanathan Mohan, Nemencio Nicodemus, Anthony Roberts, Tri Juli Edi Tarigan, Kyu-Chang Won, Roopa Mehta
The rising prevalence of type 2 diabetes (T2D) is posing major challenges for the healthcare systems of many countries, particularly in the Asia-Pacific Region, in which T2D can present at younger ages and lower body mass index when compared with Western nations. There is an important role for insulin therapy in the management of T2D in these nations, but available evidence suggests that insulin is under-utilized and often delayed, to the detriment of patient prognosis. The authors of this article gathered as an advisory panel (representative of some of the larger Asia-Pacific nations) to identify their local barriers to insulin use in T2D, and to discuss ways in which to address these barriers, with their outputs summarized herein...
April 16, 2024: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders
https://read.qxmd.com/read/38623382/iron-metabolic-biomarkers-and-the-mortality-risk-in-the-general-population-a-nationwide-population-based-cohort-study
#30
JOURNAL ARTICLE
Yuanyuan Sun, Wenyao Peng, Siqi Lin, Jingjing Cui, Jiapeng Lu
CONTEXT: Iron is an essential element in the human body and plays a critical role in many physiological and cellular processes. However, the association between iron status and the risk of all-cause or cause-specific mortality has not been well-investigated. And it is unclear whether the association between iron metabolic biomarkers and the risk of mortality differs between people with and without diabetes mellitus (DM). OBJECTIVE: This work aimed to investigate associations between iron metabolic biomarkers and all-cause and cause-specific mortality risk in the general population, and heterogeneities in the associations among population with and without DM...
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38623380/thyroid-hormones-and-diabetes-in-euthyroid-hispanic-latino-adults-of-diverse-backgrounds-hchs-sol
#31
JOURNAL ARTICLE
Victoria Persky, Chibuzor Abasilim, Konstantina Tsintsifas, Tessa Day, Robert M Sargis, Martha Daviglus, Jianwen Cai, Sally Freels, Robert Kaplan, Carmen R Isasi, Amber Pirzada, Michelle L Meyer, Gregory A Talavera, Bharat Thyagarajan, Shivani Agarwal, Noel Chavez, Arielle Grieco, Mary E Turyk
CONTEXT: Previous studies have demonstrated associations of endogenous thyroid hormones with diabetes; less is known about stages of diabetes development at which they are operative, mechanisms of associations, and the role of the hypothalamic-pituitary-thyroid axis. OBJECTIVE: This study examined associations of thyroid hormones with incident prediabetes and diabetes and with changes in glycemic traits in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), the largest cohort of Hispanic/Latino adults with diverse backgrounds in the United States...
April 6, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38623181/safety-and-efficacy-of-semaglutide-in-post-kidney-transplant-patients-with-type-2-diabetes-or-post-transplant-diabetes
#32
JOURNAL ARTICLE
Moeber Mohammed Mahzari, Omar Buraykan Alluhayyan, Mahdi Hamad Almutairi, Mohammed Abdullah Bayounis, Yazeed Hasan Alrayani, Amir A Omair, Awad Saad Alshahrani
OBJECTIVE: Type 2 diabetes mellitus (T2DM) and post-transplant diabetes mellitus (PTDM) are common in renal transplant recipients. Semaglutide has demonstrated efficacy and safety in patients with T2DM. To date, only a limited number of studies have investigated its use in renal transplant patients. This study assessed the safety and efficacy of semaglutide in post-renal transplant patients. METHODS: A retrospective study was conducted at king Abdulaziz Medical City-Riyadh, Saudi Arabia...
June 2024: Journal of Clinical & Translational Endocrinology
https://read.qxmd.com/read/38623111/the-efficacy-of-metformin-as-a-therapeutic-agent-in-the-treatment-of-acne-vulgaris-a-systematic-review
#33
REVIEW
Sherilyn Nguyen, Mai-Linh Nguyen, Will S Roberts, Michael Wu, Blake Smith, Tariq Rahaman, Hoang Nguyen
A large portion of the world's population is affected by acne vulgaris (AV), with many of these individuals being adolescents. The underlying mechanism of AV is hyperkeratinization and Cutibacterium acnes infection of the pilosebaceous follicle secondary to excessive stimulation of sebaceous glands by androgens. Metformin is a biguanide medication primarily used in efforts to lower patients' sugar levels in the management of type 2 diabetes. It has been proven to reduce levels of circulating androgens in patients with insulin resistance, indicating its potential for treating AV...
March 2024: Curēus
https://read.qxmd.com/read/38622970/alpha-lipoic-acid-administration-improved-both-peripheral-sensitivity-to-insulin-and-liver-clearance-of-insulin-reducing-potential-risk-of-diabetes-and-nonalcoholic-fatty-liver-disease-in-overweight-obese-pcos-patients
#34
JOURNAL ARTICLE
Alessandro D Genazzani, Christian Battipaglia, Laura Rusce, Greta Prampolini, Claudia Aio, Francesco Ricciardiello, Martina Foschi, Alessandra Sponzilli, Elisa Semprini, Tabatha Petrillo
OBJECTIVE: To evaluate the effects of alpha lipoic acid (ALA) on hormonal and metabolic parameters in a group of overweight/obese Polycystic Ovary Syndrome (PCOS) patients. METHODS: This was a retrospective study in which thirty-two overweight/obese patients with PCOS ( n  = 32) not requiring hormonal treatment were selected from the database of the ambulatory clinic of the Gynecological Endocrinology Center at the University of Modena and Reggio Emilia, Italy...
December 2024: Gynecological Endocrinology
https://read.qxmd.com/read/38622891/methods-to-predict-heart-failure-in-diabetes-patients
#35
REVIEW
Alexander E Berezin, Tetiana A Berezina, Uta C Hoppe, Michael Lichtenauer, Alexander A Berezin
INTRODUCTION: Type 2 diabetes mellitus (T2DM) is one of the leading causes of cardiovascular disease and powerful predictor for new-onset heart failure (HF). AREAS COVERED: We focus on the relevant literature covering evidence of risk stratification based on imaging predictors and circulating biomarkers to optimize approaches to preventing HF in DM patients. EXPERT OPINION: Multiple diagnostic algorithms based on echocardiographic parameters of cardiac remodeling including global longitudinal strain/strain rate are likely to be promising approach to justify individuals at higher risk of incident HF...
April 15, 2024: Expert Review of Endocrinology & Metabolism
https://read.qxmd.com/read/38622562/two-year-incidence-and-risk-factors-of-diabetic-foot-ulcer-second-phase-report-of-ahvaz-diabetic-foot-cohort-adfc-study
#36
JOURNAL ARTICLE
Leila Yazdanpanah, Hajieh Shahbazian, Saeed Hesam, Behnam Ahmadi, Amir Mohammad Zamani
AIM/INTRODUCTION: This study was designed as the second phase of a prospective cohort study to evaluate the incidence and risk factors of diabetic foot ulcers (DFU). MATERIALS AND METHODS: The study was conducted in a university hospital in Iran. Each participant was checked and followed up for two years in terms of developing newfound DFU as ultimate outcome. We investigated the variables using univariate analysis and then by backward elimination multiple logistic regression...
April 15, 2024: BMC Endocrine Disorders
https://read.qxmd.com/read/38622435/predictive-value-of-postprandial-c-peptide-for-utilizing-multiple-daily-injection-therapy-in-type-2-diabetes
#37
JOURNAL ARTICLE
Wei Liu, Ying Gao, Rui Zhang, Siqian Gong, Xiangqing Wang, Yanai Wang, Xiaoling Cai, Xiuying Zhang, Xiaoqi Xie, Xueyao Han, Linong Ji
PURPOSE: Multiple daily injection (MDI) insulin therapy is an effective method of glycemic control and appropriate assignment to MDI therapy could minimize the risks of hypoglycemia and weight gain. The aim of the present study was to identify factors associated with indication for MDI therapy in type 2 diabetes (T2DM). METHODS: We recruited 360 participants with T2DM that were admitted to the Endocrinology Department of Peking University People's Hospital between August 2017 and July 2018...
April 15, 2024: Endocrine
https://read.qxmd.com/read/38622087/role-of-micro-rnas-associated-with-adipose-derived-extracellular-vesicles-in-metabolic-disorders
#38
REVIEW
Thomas Payet, Elisa Gabinaud, Jean-François Landrier, Lourdes Mounien
Micro-RNAs have emerged as important actors in the onset of metabolic disorders including obesity or type 2 diabetes. Particularly, several micro-RNAs are known to be key modulators of lipid metabolism, glucose homeostasis, or feeding behavior. Interestingly, the role of extracellular vesicles containing micro-RNAs, especially adipose-derived extracellular vesicles, are well-documented endocrine signals and disease biomarkers. However, the role of adipose-derived extracellular vesicles on the different tissues is different and highly related to the micro-RNA content...
April 15, 2024: Obesity Reviews
https://read.qxmd.com/read/38619812/endobridge-2023-highlights-and-pearls
#39
REVIEW
Bulent Okan Yildiz, Cesar Luiz Boguszewski, Margaret Cristina da Silva Boguszewski, Luca Busetto, Ozlem Celik, Ghada El-Hajj Fuleihan, Dimitrios G Goulis, Gary D Hammer, Megan R Haymart, Gregory Kaltsas, Jennifer R Law, Amanda Yuan Ling Lim, Anton Luger, Djuro Macut, Barbara McGowan, Michael McClung, Alexander Dimitri Miras, Mary Elizabeth Patti, Robin P Peeters, Duarte Pignatelli, Hamayle Saeed, Jennifer Sipos, Constantine A Stratakis, Marina Tsoli, A J van der Lely, Selma F Witchel, Dilek Yazici
EndoBridge 2023 took place on October 20-22, 2023, in Antalya, Turkey. Accredited by the European Council, the 3-day scientific program of the 11th Annual Meeting of EndoBridge included state-of-the-art lectures and interactive small group discussion sessions incorporating interesting and challenging clinical cases led by globally recognized leaders in the field and was well attended by a highly diverse audience. Following its established format over the years, the program provided a comprehensive update across all aspects of endocrinology and metabolism, including topics in pituitary, thyroid, bone, and adrenal disorders, neuroendocrine tumors, diabetes mellitus, obesity, nutrition, and lipid disorders...
April 15, 2024: Hormones: International Journal of Endocrinology and Metabolism
https://read.qxmd.com/read/38619692/neutrophil-extracellular-traps-nets-are-associated-with-type-2-diabetes-and-diabetic-foot-ulcer-related-amputation-a-prospective-cohort-study
#40
JOURNAL ARTICLE
Irshat Ibrahim, Yilimire Nuermaimaiti, Gulijianaiti Maimaituxun, Xinling Luo, Mailudemu Maimaituxun, Azimat Akbar, Kahaer Tuerxun, Yuanquan Wu
INTRODUCTION: The prevalence of diabetes mellitus and its sequelae has been on the rise, and diabetic foot ulcer (DFU) is the leading cause of non-traumatic lower limb amputation globally. The rising occurrence and financial burden associated with DFU necessitate improved clinical assessment and treatment. Diabetes has been found to enhance the formation of neutrophil extracellular traps (NETs) by neutrophils, and excessive NETs have been implicated in tissue damage and impaired wound healing...
April 15, 2024: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders
keyword
keyword
119635
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.